Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CONCETTA M FORCHETTI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1184656852
CMS profile
189389
Location
ELK GROVE VILLAGE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$8,113.42

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $7,410.00 1
Piramal Imaging Limited $600.00 1
Biogen, Inc. $63.47 1
Genentech, Inc. $39.95 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CONCETTA M FORCHETTI

NPI 1184656852 · CMS profile ID 189389

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ELK GROVE VILLAGE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1184656852?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CONCETTA M FORCHETTI, NPI 1184656852, CMS profile ID 189389. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184656852?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). CONCETTA M FORCHETTI, NPI 1184656852, CMS profile ID 189389. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184656852?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
CONCETTA M FORCHETTI, NPI 1184656852, CMS profile ID 189389, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1184656852?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $8,113.42 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biogen, Inc. $63.4712/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660609559 CMS
Genentech, Inc. $39.9504/05/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681174503 CMS
Piramal Imaging Limited $600.0001/14/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 707744343 CMS
Merck Sharp & Dohme Corporation $7,410.0001/07/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695746877 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $8,113.42 4
PY2020 $565.00 1
PY2021 $38,624.37 33
PY2022 $15,350.00 6
PY2023 $16,660.79 32
PY2024 $39,378.02 40
PY2025 $50,287.88 49

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $908,463.90 81
PY2024 Principal investigator $630,831.36 79
PY2023 Recipient $591.95 2
PY2023 Principal investigator $1,785,779.63 92
PY2022 Recipient $10,066.00 2
PY2022 Principal investigator $1,648,640.76 51
PY2021 Recipient $1,310.44 2
PY2021 Principal investigator $1,377,364.84 65
PY2020 Recipient $2,195.35 2
PY2020 Principal investigator $1,008,121.30 81
PY2019 Recipient $294.51 1
PY2019 Principal investigator $1,007,212.44 33

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

83 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $21,516.84 12/14/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141985
Principal investigator 1 Genentech, Inc. $300.00 12/11/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141981
Principal investigator 1 Genentech, Inc. $2,104.20 12/11/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142139
Principal investigator 1 Genentech, Inc. $550.00 12/08/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141977
Principal investigator 1 Genentech, Inc. $600.00 12/01/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141971
Principal investigator 1 Genentech, Inc. $7,663.86 11/19/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141967
Recipient Eli Lilly and Company $201.35 11/12/2020 Covered Recipient Physician ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728718557
Principal investigator 1 Genentech, Inc. $2,975.40 11/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142135
Principal investigator 1 Eli Lilly and Company $626.59 11/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728730907
Principal investigator 1 Genentech, Inc. $909.00 10/15/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141963
Principal investigator 1 Genentech, Inc. $6,430.86 10/14/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141957
Principal investigator 1 Genentech, Inc. $6,904.30 10/13/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142129
Principal investigator 1 Genentech, Inc. $730.00 10/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142120
Principal investigator 1 Genentech, Inc. $350.00 10/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142125
Principal investigator 1 Genentech, Inc. $1,313.00 09/22/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141949
Principal investigator 1 Genentech, Inc. $300.00 09/22/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141953
Principal investigator 1 Genentech, Inc. $200.00 09/22/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142111
Principal investigator 1 Genentech, Inc. $1,060.00 09/22/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142115
Principal investigator 1 Genentech, Inc. $12,565.80 09/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141943
Principal investigator 1 Genentech, Inc. $10,632.60 09/11/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142107
Principal investigator 1 Genentech, Inc. $400.00 09/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141919
Principal investigator 1 Genentech, Inc. $155.00 09/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141925
Principal investigator 1 Genentech, Inc. $4,450.00 09/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141929
Principal investigator 1 Genentech, Inc. $50.00 09/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141935
Principal investigator 1 Genentech, Inc. $2,626.00 09/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141939
Principal investigator 1 Genentech, Inc. $400.00 09/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142097
Principal investigator 1 Genentech, Inc. $1,208.00 09/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142101
Principal investigator 1 Genentech, Inc. $16,655.22 08/21/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141915
Principal investigator 1 Genentech, Inc. $15,417.90 08/17/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142093
Principal investigator 1 Genentech, Inc. $400.00 08/14/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141909
Principal investigator 1 Genentech, Inc. $300.00 08/14/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142083
Principal investigator 1 Genentech, Inc. $48.00 08/14/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142089
Principal investigator 1 Genentech, Inc. $500.00 07/28/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141905
Recipient Eli Lilly and Company $1,994.00 07/21/2020 Covered Recipient Physician ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 728718517
Principal investigator 1 Genentech, Inc. $7,336.80 07/01/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142079
Principal investigator 1 Genentech, Inc. $400.00 06/25/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141895
Principal investigator 1 Genentech, Inc. $4,161.06 06/25/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141901
Principal investigator 1 Genentech, Inc. $350.00 06/25/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142075
Principal investigator 1 Genentech, Inc. $5,707.80 06/24/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142069
Principal investigator 1 Genentech, Inc. $400.00 06/19/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141891
Principal investigator 1 Genentech, Inc. $11,073.96 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141887
Principal investigator 1 Genentech, Inc. $500.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142041
Principal investigator 1 Genentech, Inc. $600.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142047
Principal investigator 1 Genentech, Inc. $500.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142051
Principal investigator 1 Genentech, Inc. $500.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142055
Principal investigator 1 Genentech, Inc. $600.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142061
Principal investigator 1 Genentech, Inc. $600.00 06/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142065
Principal investigator 1 Genentech, Inc. $6,274.80 06/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142037
Principal investigator 1 Genentech, Inc. $400.00 06/03/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141883
Principal investigator 1 Genentech, Inc. $24,645.96 06/02/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141877
Principal investigator 1 Genentech, Inc. $800.00 06/02/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142033
Principal investigator 1 Genentech, Inc. $12,576.60 06/01/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142027
Principal investigator 1 Eli Lilly and Company $488.86 05/26/2020 Non-covered Recipient Entity
OKLAHOMA MEDICAL RESEARCH FOUNDATION
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728738989
Principal investigator 1 Genentech, Inc. $500.00 05/22/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141873
Principal investigator 1 Genentech, Inc. $400.00 05/15/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142013
Principal investigator 1 Genentech, Inc. $350.00 05/15/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142019
Principal investigator 1 Genentech, Inc. $48.00 05/15/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142023
Principal investigator 1 Genentech, Inc. $650.00 05/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141867
Principal investigator 1 Genentech, Inc. $500.00 05/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142003
Principal investigator 1 Genentech, Inc. $15,195.60 05/12/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857142009
Principal investigator 1 Genentech, Inc. $13,350.00 05/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141863
Principal investigator 1 Genentech, Inc. $735.00 05/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857141995
Principal investigator 1 Genentech, Inc. $250.00 05/04/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857141999
Principal investigator 1 Genentech, Inc. $3,030.00 04/27/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141859
Principal investigator 1 Genentech, Inc. $53,331.30 04/17/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 857141991
Principal investigator 1 Genentech, Inc. $62,489.88 04/16/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141853
Principal investigator 1 Genentech, Inc. $5,586.00 04/08/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141835
Principal investigator 1 Genentech, Inc. $100.00 04/08/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141839
Principal investigator 1 Genentech, Inc. $4,450.00 04/08/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141845
Principal investigator 1 Genentech, Inc. $465.00 04/08/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 857141849
Principal investigator 1 Eli Lilly and Company $258.36 04/06/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728729587
Principal investigator 1 Biogen, Inc. $421,210.00 04/01/2020 Non-covered Recipient Entity
Alexian Brothers Health System
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 No dispute reported 06/30/2026 736755469
Principal investigator 1 Genentech, Inc. $700.00 03/11/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY FOR MODERATE AD No dispute reported 06/30/2026 743027489
Principal investigator 1 Eli Lilly and Company $141,675.73 03/10/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 728733339
Principal investigator 1 Genentech, Inc. $1,116.00 02/19/2020 Non-covered Recipient Entity
BONAVENTURE MEDICAL FOUNDATION ADMINISTRATION OFFICE
PRODROMAL TO MILD AD No dispute reported 06/30/2026 743038345
Principal investigator 1 Eli Lilly and Company $450.00 01/31/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS MEDICAL CENTER - NEUROSCIENCE RESEARCH INSTITUTE
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 728731503
Principal investigator 1 Genentech, Inc. $100.00 01/07/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
PHASE II STUDY OF ANTI TAU IN PRODROMAL TO MILD AD No dispute reported 06/30/2026 743027605
Principal investigator 1 Eli Lilly and Company $2,240.50 01/03/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 728729581
Principal investigator 1 Biogen, Inc. $26,869.94 01/02/2020 Non-covered Recipient Entity
Alexian Brothers Hospital Network
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease No dispute reported 06/30/2026 736755525
Principal investigator 1 Eli Lilly and Company $44,727.30 01/02/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HOSPITAL NETWORK
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728730779
Principal investigator 1 Biogen, Inc. $5,035.28 01/01/2020 Non-covered Recipient Entity
Alexian Brothers Hospital Network
Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD) No dispute reported 06/30/2026 736755529
Principal investigator 1 Eli Lilly and Company $900.00 01/01/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS MEDICAL CENTER - NEUROSCIENCE RESEARCH INSTITUTE
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 728729983
Principal investigator 1 Novartis Pharmaceuticals Corporation $3,149.00 01/01/2020 Non-covered Recipient Entity
ALEXIAN BROTHERS HEART AND VASCULAR INSTITUTE
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY OF TWO DOSES OF CNP520 IN PARTICIPANTS AT RISK FOR THE ONSET OF CLINICAL SYMPTOMS OF AD No dispute reported 06/30/2026 721488129